![]() Caplin Point Laboratories Caplin Point Laboratories is a pharmaceutical company manufacturing a range of formulations. | ![]() UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions. | ![]() AbbVie AbbVie is a pharmaceutical company engaged in the research, development, manufacturing, commercialization, and sale of medicines and therapies. | |
Founding Date | Founding Date 1990 | Founding Date 1928 | Founding Date 2013 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Chennai, IN HQ Chennai, IN Gerugambakkam, IN Suthukeny, IN | Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more | Locations North Chicago, US HQ Hydra, DZ Buenos Aires, AR Mascot, AU Wien, AT Wavre, BE Sarajevo, BA see more |
Employees | Employees 3,406 | Employees 9,052 | Employees 55,00010% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 34.3 b | Valuation ($) 335 b |
Financial | |||
Revenue (est.) | Revenue (est.) ₹21.9b (FY, 2026) | Revenue (est.) €7.4b (FY, 2025) | Revenue (est.) $61.2b (FY, 2025) |
Cost of goods | Cost of goods ₹8.7b (FY, 2026) | Cost of goods €1.4b (FY, 2025) | Cost of goods $18.2b (FY, 2025) |
Gross profit | Gross profit ₹14.4b (FY, 2026) | Gross profit €7.2b (FY, 2025) | Gross profit $43b (FY, 2025) |
Net income | Net income ₹6.5b (FY, 2026) | Net income €1.6b (FY, 2025) | Net income $4.2b (FY, 2025) |
Operating ⚠ | |||
Countries | Countries N/A | Countries 35 (FY, 2019) | Countries 70 (FY, 2022) |
Funding | |||
Total funding raised | Total funding raised $ 30.6m | Total funding raised N/A | Total funding raised $ 3.8b |

UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
View company
AbbVie is a pharmaceutical company engaged in the research, development, manufacturing, commercialization, and sale of medicines and therapies.
View company